Nikkiso (TYO:6376) said the medical division of its Nikkiso America business entered the U.S. hemodialysis market with its DBB-06 system, after winning 510(k) clearance from the FDA in March. Tokyo-based Nikkiso said the DBB-06 system uses its dialysis dose monitoring technology and a blood volume monitor designed to help evaluate and treat hydration status by continuously monitoring relative […]